Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
Robert J. Moots,
Ricardo M. Xavier,
Chi Chiu Mok,
Mahboob U. Rahman,
Wen-Chan Tsai,
Mustafa H. Al-Maini,
Karel Pavelka,
Ehab Mahgoub,
Sameer Kotak,
Joan Korth-Bradley,
Ron Pedersen,
Linda Mele,
Qi Shen,
Bonnie Vlahos
Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
